New York University · BiochemistryThe Immunogen Nexus
Xiangpeng Kong · New York, New York
Research Focus
Dr. Xiangpeng Kong's lab is focused on developing innovative vaccines against HIV/AIDS, particularly targeting a crucial site on the HIV-1 virus that can elicit strong immune responses. They utilize a unique approach by combining HIV fusion peptide immunogens with cholera toxin subunit B to create potent vaccine candidates. The lab aims to enhance the effectiveness and coverage of antibody responses that could lead to a successful vaccine against HIV.
HIV vaccinebroadly neutralizing antibodiesfusion peptidecholera toxinimmunogensneutralization breadthTier 2 virusesanimal models
Research Aims
3AIM 01Develop a novel AB toxin B subunit-based fusion peptide vaccine
AIM 02Enhance the breadth and potency of neutralizing antibody responses
AIM 03Evaluate the immunogenicity of refined fusion peptide immunogens in non-human primates
Skills the Lab Values
vaccine developmentimmunogenic testingprotein engineeringanimal model studiesantibody assaysrecombinant protein techniquesbiochemical assaysbioinformaticscell culture
Output against the department
Publications203top 40% of dept.160th of 402
this lab
most publishedleast published
Citations8.7kbottom 45% of dept.220th of 402
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.